ArticleMicrosystems & nanoengineering2026
Development and application of a smartphone-based thermal contrast amplification reader for photothermal lateral flow immunoassays.
Article in Microsystems & nanoengineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The high cost and poor portability of external infrared thermal imagers have limited the widespread adoption of photothermal lateral flow immunoassays (PT-LFIAs) in on-site testing. To address this, we developed a smartphone-based handheld Thermal Contrast Amplification (TCA) Reader, eliminating the need for costly external hardware. Compared with existing recent external thermal imager-based PT-LFIA readout, this reader integrates a selected thermal-sensor-equipped smartphone, a motorized laser module, Bluetooth-enabled control, and a fixed 3D-printed holder into a compact device. The reader enables automated thermal signal acquisition with a same-strip measurement CV below 1% and supports multiple PT-LFIA formats. Using Au@Ag core-shell nanoparticles (Au@Ag NPs) as reliable photothermal labels, the handheld TCA reader-based PT-LFIAs (hT-PT-LFIAs) offers higher sensitivity compared to conventional LFIAs. The hT-PT-LFIAs can be used for the multiplex detection of viral antigens (Influenza A/B, SARS-CoV-2), small molecule drugs (morphine, methamphetamine, ketamine) and nucleic acids (HPV 16/18), demonstrating versatility across various LFIA formats, good clinical performance in training cohort, and high repeatability for small molecule assay. By seamlessly integrating micro-engineering, nanotechnology, and smartphone-based sensing, this work provides a low-cost, portable, and broadly applicable PT-LFIAs detection strategy that bridges a critical technological gap.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.